MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells
Publisher: Spandidos Publications
ISSN: 1021-335X
Source: Oncology Reports, Vol.27, Iss.5, 2012-01, pp. : 1611-1618
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract